Meta-Analysis
Copyright ©The Author(s) 2015.
World J Gastroenterol. Jun 14, 2015; 21(22): 7022-7035
Published online Jun 14, 2015. doi: 10.3748/wjg.v21.i22.7022
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Flow diagram of study selection.
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 Meta-analysis of effect of cetuximab plus chemotherapy on overall survival regardless of KRAS status.
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 Meta-analysis of effect of cetuximab plus chemotherapy on overall survival based on status of KRAS.
Figure 4
Open in New Tab Full Size Figure Download Figure
Figure 4 Meta-analysis of effect of cetuximab plus chemotherapy on progression-free survival regardless of KRAS status.
Figure 5
Open in New Tab Full Size Figure Download Figure
Figure 5 Meta-analysis of effect of cetuximab plus chemotherapy on progression-free survival based on status of KRAS.
Figure 6
Open in New Tab Full Size Figure Download Figure
Figure 6 Meta-analysis of effect of cetuximab plus irinotecan-free chemotherapy on overall survival based on status of KRAS.
Figure 7
Open in New Tab Full Size Figure Download Figure
Figure 7 Meta-analysis of effect of cetuximab plus irinotecan-free chemotherapy on progression-free survival based on status of KRAS.
Figure 8
Open in New Tab Full Size Figure Download Figure
Figure 8 Meta-analysis of effect of cetuximab plus irinotecan containing chemotherapy on overall survival based on status of KRAS.
Figure 9
Open in New Tab Full Size Figure Download Figure
Figure 9 Meta-analysis of effect of cetuximab plus irinotecan containing chemotherapy on progression-free survival based on status of KRAS.
Figure 10
Open in New Tab Full Size Figure Download Figure
Figure 10 Meta-analysis of adverse events in patients receiving cetuximab or not.
Figure 11
Open in New Tab Full Size Figure Download Figure
Figure 11 Funnel plot for detecting publication bias.